Skip to content

Xtant Medical Holdings XTNT Gain (Loss) on Disposition of Stock in Subsidiary

Gain (Loss) on Disposition of Stock in Subsidiary at other companies

OceanFirst Financial logo
OceanFirst FinancialOCFC
-$1.08M
Cinemark Holdings logo
Cinemark HoldingsCNK
$6.9M
Ivanhoe Electric logo
Ivanhoe ElectricIE
$0-100%
WEBTOON Entertainment Inc. logo
WEBTOON Entertainment Inc.WBTN
$0+100%
Iris Energy logo
Iris EnergyIREN
$0
American Coastal Insurance Corporation logo
American Coastal Insurance CorporationACIC
-$82K

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:GainOrLossOnSaleOfStockInSubsidiary.

The official record: Xtant Medical Holdings’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's gain (loss) on disposition of stock in subsidiary.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's gain (loss) on disposition of stock in subsidiary?
Xtant Medical Holdings (XTNT) reported gain (loss) on disposition of stock in subsidiary of $820.25K in Q4 2025.
What does gain (loss) on disposition of stock in subsidiary mean?
This metric reflects the net financial impact resulting from the divestiture or sale of equity interests in a subsidiary entity. It represents the difference between the proceeds received from the transaction and the carrying value of the investment on the company's balance sheet. This figure provides insight into the company's capital allocation strategy and its ability to unlock value through the strategic restructuring of its business portfolio.